KU-177 is a potent inhibitor of Hsp90 ATPase homologue 1 ( Aha1 ), ablates Aha1 -driven enhancement of Hsp90-dependent tau aggregation. KU-177 also disrupts Aha1 / Hsp90 interactions ( IC 50 =4.08 μM) without inhibition of Hsp90’s ATPase activity. KU-177 can be used for tauopathies research.
Products | Products > Disease Areas > Cancer | Products > Disease Areas > Breast Cancer | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Drug Resistance | Products > Signaling Pathways > HSP
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.